Consumers

Personal importation
For travellers
Buying online

Health Professionals

Reporting problems
Unapproved products
Special access scheme

Industry

SME Assist
Regulation basics
Scheduling basics

Recalls and suspensions

Subscribe to TGA safety information

Palexia SR 100 mg tapentadol sustained release tablets

14 February 2020
Product defect correction - potential for blank labelling to pose risk of accidental misuse

Brauer Teething Gel 20 g

29 November 2019
Recall - bacterial contamination of one batch

Accu-Chek Guide and Accu-Chek Performa blood glucose meters

14 November 2019
Product defect correction – risk of delayed therapy due to potential battery issues

Jin Gui Shen Qi Wan (oral pills)

5 September 2019
Recall - potential toxicity (金 匮 肾 气 丸 - statement includes Chinese translation 中文翻译)

More safety information »

Safety information

Subscribe to TGA safety information

Mojo Black capsules

3 April 2020
Mojo Black capsules pose a serious risk to your health and should not be taken

Gentamicin 40 mg/mL Injection (Hospira UK Limited)

1 April 2020
Safety advisory - alternative product filling shortage may cause airway irritation if administered via inhalation

No evidence to support intravenous high-dose vitamin C in the management of COVID-19

27 March 2020
We have investigated a report that intravenous high-dose vitamin C may be beneficial in the management of COVID-19

New restrictions on prescribing hydroxychloroquine for COVID-19

24 March 2020
Only certain types of specialists will be able to prescribe hydroxychloroquine to new patients

More safety information »

News

Subscribe to TGA latest news and updates

COVID-19 test kits included on the ARTG for legal supply in Australia

4 April 2020
A list of tests approved for inclusion on the Australian Register of Therapeutic Goods (ARTG).

ATP Science issued infringement notices for $302,400 for alleged advertising breaches

3 April 2020
The TGA has issued ATP Science Pty Ltd with 24 infringement notices

Notice of an amendment to the current Poisons Standard under paragraph 52D(2)(a) of the Therapeutic Goods Act 1989 - Hydroxychloroquine

3 April 2020
Poisons Standard amendments to hydroxychloroquine to ensure continued availability during the COVID-19 pandemic

TGA collaborating to help ensure the supply of ventilators

2 April 2020
Information about the steps we are taking to make sure there are enough ventilators to match demand during the COVID-19 pandemic

More news »

Latest tweets

Connect